Cardiovascular Benefits of Metabolic Surgery and GLP-1 Receptor Agonists in T2D
The following is a summary of “Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist–based therapies,” published in the August 2024 issue of Endocrinology by Morissette et al. Excessive adipose tissue and type 2 diabetes mellitus (T2DM)...